Tick Borne Encephalitis Market Report 2026

Tick Borne Encephalitis Market Overview

• Tick Borne Encephalitis market size has reached to $10.53 billion in 2025 • Expected to grow to $15.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Global Temperatures Driving The Growth Of The Market Due To Expanding Tick Habitats • Europe was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Tick Borne Encephalitis Market?

Tick-borne encephalitis (TBE) is a viral infection transmitted to humans through the bite of an infected tick, primarily the Ixodes species. The virus affects the central nervous system, causing brain inflammation (encephalitis). The symptoms range from mild flu-like signs to severe neurological issues, including fever, headache, confusion, and, in some cases, paralysis or seizures. The main tick borne encephalitis products are tick-borne encephalitis (tbe) vaccines, tick repellents, diagnostic tests, and antiviral drugs. Tick-borne encephalitis (TBE) vaccines are biological preparations designed to stimulate the immune system to recognize and combat the tick-borne encephalitis (TBE) virus. It is caused by various virus types, including European tick borne encephalitis virus, siberian tick borne encephalitis virus, and far eastern tick borne encephalitis virus, and can be administered by parenteral and other routes. It is distributed through both online and offline channels and is used by travelers, outdoor enthusiasts, healthcare providers, and research institutions.

What Is The Tick Borne Encephalitis Market Growth Forecast?

The tick borne encephalitis market size is expected to see strong growth in the next few years. It will grow to $15.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing investments in vaccine research and development, rising demand for travel-related immunization, expansion of early diagnostic screening programs, growing adoption of integrated disease monitoring platforms, increasing focus on infectious disease prevention. Major trends in the forecast period include increasing adoption of preventive vaccination programs, rising demand for rapid diagnostic testing, growing awareness of tick-borne diseases, expansion of integrated disease surveillance systems, enhanced focus on public health preparedness.

Global Tick Borne Encephalitis Market Segmentation

1) By Product Type: Tick-Borne Encephalitis (TBE) Vaccines, Tick Repellents, Diagnostic Tests, Antiviral Drugs 2) By Virus Type: European Tick Borne Encephalitis Virus, Siberian Tick Borne Encephalitis Virus, Far Eastern Tick Borne Encephalitis Virus 3) By Route of Administration: Parenteral, Other Routes Of Administration 4) By Distribution Channel: Online, Offline 5) By End-User: Travelers, Outdoor Enthusiasts, Healthcare Providers, Research Institutions Subsegments: 1) By Tick-Borne Encephalitis (TBE) Vaccines: Inactivated (Killed) Vaccines, Live Attenuated Vaccines 2) By Tick Repellents: DEET-Based Repellents, Picaridin-Based Repellents, Natural Or Plant-Based Repellents, Permethrin-Treated Clothing And Gear 3) By Diagnostic Tests: ELISA (Enzyme-Linked Immunosorbent Assay), PCR (Polymerase Chain Reaction), Rapid Diagnostic Tests (RDTs), Neutralization Tests 4) By Antiviral Drugs: Nucleoside Analogs, Interferons, Immunoglobulin Therapy, Supportive Therapy (Symptomatic Treatment)

What Are The Drivers Of The Tick Borne Encephalitis Market?

The increasing climate change is expected to propel the growth of the tick-borne encephalitis market going forward. Climate change refers to long-term shifts in global temperatures and weather patterns, primarily caused by human activities such as burning fossil fuels and deforestation. The increase in climate change is due to the excessive burning of fossil fuels, which releases large amounts of greenhouse gases such as carbon dioxide and methane into the atmosphere, trapping heat and causing global temperatures to rise. Climate change fuels demand for tick-borne encephalitis treatment by expanding the habitats of disease-carrying ticks due to rising temperatures and milder winters, increasing infection rates, and a greater need for diagnostics, vaccines, and antiviral treatments. For instance, in November 2024, according to the World Meteorological Organization (WMO), a Switzerland-based specialized agency of the United Nations, from January to September 2024, the global mean surface air temperature was 1.54°C above the pre-industrial average (±0.13°C margin of uncertainty), driven by a warming El Niño event. Therefore, the increasing climate change is driving the growth of the tick-borne encephalitis market. The rising international travel is expected to fuel the growth of the tick-borne encephalitis market going forward. International travel refers to the movement of people across national borders for purposes such as tourism, business, education, or migration. The rise in international travel is due to increasing disposable income, allowing more people to afford leisure trips, business visits, and educational opportunities across borders. International travel fuels demand for tick-borne encephalitis treatment as more travelers visit endemic regions, increasing their exposure to infected ticks and driving the need for preventive vaccinations and post-exposure medical care. For instance, in January 2025, according to the United Nations World Tourism Organization, a Spain-based specialized agency of the United Nations, an estimated 1.4 billion tourists traveled internationally in 2024, marking a near-complete recovery to pre-pandemic levels (99%). This reflects an 11% increase from 2023, with 140 million more international arrivals. Therefore, the rising international travel is driving the growth of the tick-borne encephalitis market. The increasing government funding for healthcare facilities is expected to propel the growth of the tick-borne encephalitis market going forward. Government funding refers to financial support to organizations, projects, or individuals to promote public services, economic development, research, or other policy objectives. The increase in government funding is due to increasing public health and infrastructure investments, as governments allocate more resources to strengthen healthcare systems, support economic recovery, and enhance research and development initiatives. Government funding positively impacts tick-borne encephalitis by supporting vaccination programs, enabling wider immunization coverage in endemic regions, reducing infection rates, and increasing public access to preventive healthcare. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, the UK government expenditure was the primary source of healthcare financing in 2023, totaling $309 billion (£239 billion) and accounting for 81.9% of overall healthcare spending. Therefore, the increasing government funding for healthcare facilities is driving the growth of the tick-borne encephalitis market.

Key Players In The Global Tick Borne Encephalitis Market

Major companies operating in the tick borne encephalitis market are Pfizer Inc., Sanofi Pasteur, Novartis AG, GlaxoSmithKline (GSK) Plc, Bavarian Nordic, Valneva SE, Microgen, DIESSE Diagnostica Senese S.p.A., QED Bioscience Inc., Serion Immunologics, Chumakov Federal Scientific Center, Merck & Co. Inc., AstraZeneca Plc, Johnson & Johnson (Janssen Pharmaceuticals), CSL Limited, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt Ltd, BioNTech SE, Zydus Cadila, Bharat Biotech International Limited, Walvax Biotechnology Co Ltd

Regional Outlook

Europe was the largest region in the tick borne encephalitis market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tick Borne Encephalitis Market?

The tick-borne encephalitis market consists of sales of immune globulins, protective clothing and tick barriers, and surveillance and monitoring systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tick Borne Encephalitis Market Report 2026?

The tick borne encephalitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tick borne encephalitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.